| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,609 | 17,274 | 17,256 | 17,209 | | Cost of Revenue | 7,706 | 7,394 | 6,284 | 7,583 | | | Gross Profit | 13,904 | 9,880 | 10,972 | 9,627 | | | Operating Expenses | | Research Development | 2,925 | 2,433 | 3,352 | 5,392 | | Selling General and Administrative | 9,203 | 9,724 | 9,480 | 10,406 | | Non Recurring |
-
| 3,028 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,776 | (5,305) | (1,860) | (6,171) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 113 | 235 | 332 | 601 | | Earnings Before Interest And Taxes | 1,889 | (5,069) | (1,528) | (5,570) | | Interest Expense | 90 | 90 | 90 | 95 | | Income Before Tax | 1,799 | (5,160) | (1,618) | (5,665) | | Income Tax Expense |
-
|
-
|
-
| 23,607 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,799 | (5,160) | (1,618) | (29,272) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,799 | (5,160) | (1,618) | (29,272) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,799 | ($5,160) | ($1,618) | ($29,272) |
|
0.31% Nasdaq 
0.05%
Income Statement
